Chiropractic for Hypertension in Patients



Status:Completed
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - 75
Updated:2/9/2018
Start Date:October 2010
End Date:May 2012

Use our guide to learn which trials are right for you!

Upper Cervical Manipulation for Patients With Stage 1 Hypertension

The investigators propose a prospective randomized 2 arm parallel observer-blinded phase II
clinical study comparing a distinct method of upper cervical chiropractic manipulation to a
sham technique in 50 individuals with stage I hypertension (systolic blood pressure (SBP):
140-159 mm Hg; diastolic blood pressure (DBP):90-99 mm Hg).

More than 50 million Americans suffer from hypertension, a disease with far-reaching public
health impact causing or contributing to 7.1 million deaths yearly at an estimated annual
incremental direct cost of $54 billion per year. Common treatments include antihypertensive
medications and lifestyle modifications. While these treatments have been shown to be
effective, only about 30% of hypertensive patients achieve blood pressure goals. Based on a
recently published study (Bakris et al, 2007), one unique non-pharmaceutical approach may be
a non-rotary type of upper cervical spinal manipulation to align the first cervical vertebra
(atlas) performed by a doctor of chiropractic. We propose to conduct a similar study with a
more commonly known chiropractic technique called Toggle Recoil. We propose a prospective
randomized 2 arm parallel observer-blinded phase II clinical study comparing a distinct
method of upper cervical chiropractic manipulation to a sham technique in 50 (25 in each
group) individuals with Stage I hypertension (systolic blood pressure (SBP); 140-159 mm Hg or
diastolic blood pressure (DBP):90-99 mm Hg). Patients will be seen by doctors of chiropractic
twice each week for 6 weeks and outcomes will be collected at baseline, 3 weeks, and 6 weeks
after enrollment. The primary outcome measure will be change in SBP and the primary endpoint
will be at the week 6 assessment.

Inclusion Criteria:

- Age > 21 and < 75

- Documented Stage I Hypertension

Exclusion Criteria:

- Cardiovascular disorders (Angina pectoris, symptom of CHD; Hemodynamically significant
valvular heart disease; Second or Third degree heart block without pacemaker; Stroke,
MI, CV surgery within the past 12 months; Claudication, Aortic Coarctation)

- Defibrillator

- Autoimmune Arthropathies

- Pregnancy

- Unwillingness to stop other forms of manual therapy during study

- Unwillingness to sign ICD or preliminary consent

- Intention to move from the area during the next 4 months

- Unwillingness to participate in any of the treatment groups

- Avg SBP<140 or >159mm Hg (AND) Avg DBP<90 or >99mm Hg

- Any single SBP > 160mm Hg or DBP> 100

- BMI > 40

- Prescription medications with increased risk for CVA

- Current use of anti-coagulant medication/blood thinners

- Active drug or alcohol addiction or abstinent < 1 year

- Psychiatric diagnosis that would limit patient compliance

- Serious concomitant medical illness

- Contraindication(s) to treatment

- Electrolyte abnormalities seen on lab test

- Renal Failure w/ creatinine >2.5mg/dL

- Abnormal Liver function tests

- Anemia with hematocrit < 30%

- Glucose in Urine

- Serum potassium <3.4 @ baseline

- S/S Renal artery stenosis

- Quebec Task Force Classification 4-9

- Self-reported Arnold Chiari malformation

- Spinal or paraspinal tumors

- Dx with disorder that exhibit spinal joint hypermobility (Marfan Syndrome,
Ehlers-Danlos Syndrome, Osteogenesis imperfecta)

- Unstable endocrine disorders

- Osteoporosis
We found this trial at
1
site
Davenport, Iowa 52803
?
mi
from
Davenport, IA
Click here to add this to my saved trials